EP1025113A1 - Improved process for performing polynucleotide separations - Google Patents

Improved process for performing polynucleotide separations

Info

Publication number
EP1025113A1
EP1025113A1 EP98923524A EP98923524A EP1025113A1 EP 1025113 A1 EP1025113 A1 EP 1025113A1 EP 98923524 A EP98923524 A EP 98923524A EP 98923524 A EP98923524 A EP 98923524A EP 1025113 A1 EP1025113 A1 EP 1025113A1
Authority
EP
European Patent Office
Prior art keywords
eluting solvent
separation media
polynucleotide
solution
separation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98923524A
Other languages
German (de)
French (fr)
Other versions
EP1025113A4 (en
Inventor
Douglas T. Gjerde
Robert M. Haefele
David W. Togami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Precipio Inc
Original Assignee
Transgenomic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgenomic Inc filed Critical Transgenomic Inc
Publication of EP1025113A1 publication Critical patent/EP1025113A1/en
Publication of EP1025113A4 publication Critical patent/EP1025113A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/10Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/16Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the fluid carrier
    • B01D15/166Fluid composition conditioning, e.g. gradient
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/265Adsorption chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical

Definitions

  • This invention is directed to the separation of polynucleotide fragments by liquid chromatography. More specifically, the invention is directed to a system and method, which enhances the chromatographic separation of polynucleotides on non-polar, wide pore separation media.
  • Samples containing mixtures of polynucleotides can result from total synthesis of polynucleotides, cleavage of DNA with restriction endonucleases or RNA, as well as polynucleotide samples which have been multiplied or amplified using polymerase chain reaction (PCR) techniques or other amplifying techniques.
  • PCR polymerase chain reaction
  • MIPC Matched Ion Polynucleotide Chromatography
  • the invention of parent application Serial No. 08/748,376 is based on the discovery that trace levels of multivalent metal ions, even when present below the limits of detection, interfere with the MIPC separation process. Special steps to prevent, remove or complex any trace multivalent ions result in enhanced separation of polynucleotides and lower the detection threshold.
  • the invention provides an improved method for separating a mixture of polynucleotide fragments wherein multivalent cations are eliminated from the all aspects of the separation process.
  • the method comprises applying a solution of said fragments and counterion agent to a column containing separation media having a non-polar surface, wherein said
  • separation media have a pore size greater than 30 Angstroms and an
  • the method further comprises contacting the solution of said fragments and the eluting solvent with a multivalent cation capture resin to remove any multivalent cations therein before entering the column.
  • the separation media have
  • An optimum embodiment of the invention comprises contacting the solution of said fragments and eluting solvent with a multivalent cation capture resin before entering the column, treating the separation media to remove residual traces of multivalent cations from the surfaces therefrom, and ensuring that surfaces which are contacted by the solution of the fragments and the eluting solvent are materials which do not release
  • the polynucleotide fragments are double stranded, having more than 5 base pairs. Such fragments are separated by size or by polarity.
  • the polynucleotide fragments are single stranded having 2 or more nucleotides. Such fragments are separated by size and by polarity.
  • the separation media are organic polymer, or an inorganic substrate selected from the group consisting of inorganic substrates, silica, zirconia, and alumina.
  • the inorganic substrates support a non-polar material on their surface. Said non-polar material may be organic polymer or long chain, C1 to C24 hydrocarbon groups bound to the inorganic substrate, wherein residual polar groups of the substrate are end capped with trimethylsilyl chloride or
  • surfaces which are contacted by the solution of polynucleotide fragments and eluting solvent are titanium, coated stainless steel, organic polymer or combinations thereof. Removal of traces of residual multivalent metal cations from the separation process is further ensured by treating said surfaces with a solution comprising aqueous acid and chelating agent, by adding a chelating agent to the solution of polynucleotide mixture and eluting solvent, and by treating the eluting solvent to remove oxygen therefrom.
  • the improved method for separating said mixture of polynucleotides comprises Matched Ion Polynucleotide Chromatography.
  • the improved method of the invention may also be practiced as a
  • the batch process method of the invention comprises applying
  • the method further comprises contacting the separation media with a first eluting solvent and counterion agent, the first eluting solvent having a concentration of organic component sufficient to release from the separation media all polynucleotide fragments having a size smaller than the selected size and removing the first eluting solvent from the separation media.
  • the selected size fragments are obtained by contacting the separation media with a second eluting solvent having a concentration of organic component sufficient to release from the separation media the polynucleotide fragments having the selected size and removing the second eluting solvent from the separation media.
  • a second eluting solvent having a concentration of organic component sufficient to release from the separation media the polynucleotide fragments having the selected size and removing the second eluting solvent from the separation media.
  • surfaces which are contacted by the solution of polynucleotide fragments and the eluting solvent are material which does not release multivalent metal cations therefrom.
  • the separation media are rinsed with fresh first eluting solvent to remove residual released polynucleotide fragments therefrom.
  • the separation media are rinsed with fresh second eluting solvent to remove residual released polynucleotide fragments of selected size therefrom.
  • a preferred embodiment of the invention comprises contacting the solution of polynucleotide mixture and eluting solvent with a multivalent cation capture resin before contacting the separation media.
  • the method comprises treating the separation media to remove residual traces of multivalent cations therefrom.
  • the separation media comprises treating the separation media to remove residual traces of multivalent cations therefrom.
  • separation media have been treated to remove residual traces of multivalent cations therefrom and the solution of polynucleotide mixture and eluting solvent have been contacted with a multivalent cation capture resin before contacting the separation media.
  • Said separation media are contained in a column, a web, a membrane, or container.
  • the batch process can be used to separate mixtures of double stranded polynucleotides or single stranded polynucleotides.
  • the separation media are organic polymer, or an inorganic substrate selected from the group consisting of inorganic substrates, silica, zirconia, and alumina.
  • the inorganic substrates support a non-polar material on their surface.
  • Said non-polar material may be organic polymer or long chain, C1 to C24 hydrocarbon groups bound to the inorganic substrate, wherein residual polar groups of the substrate are end capped with trimethylsilyl chloride or hexamethyldisilazane.
  • the surfaces contacted by the solution of polynucleotide fragments and eluting solvent are, preferably, comprised of material selected from the group consisting of titanium, coated stainless steel, and organic polymer, or combinations thereof. Removal of traces of residual multivalent metal cations from the separation process is further ensured by treating said surfaces with a solution comprising aqueous acid and chelating agent, by adding a chelating agent to the solution of polynucleotide mixture and eluting solvent, and by treating the eluting solvent to remove oxygen therefrom.
  • FIG. 1 shows a guard disk having a one-piece annular ring.
  • FIG. 2 is an exploded view of a guard disk having a two-piece annular
  • guard disk material i.e., a layer or pad of multivalent cation capture resin which has been incorporated into a fabric or membrane.
  • FIG. 3 shows an assembled view of the guard disk of FIG. 2.
  • FIG. 4 shows placement of a chelating guard column and chelating guard disk in a liquid chromatographic system for polynucleotide separation.
  • FIG. 5 shows placement of a chelating guard disk positioned between a chromatographic separation column and a column top, where the guard disk is in direct contact with a titanium frit at the top portion of the separation column.
  • FIG 6. shows the chromatography of a 500 base pair DNA fragment on
  • PRX-1 (Sarasep, San Jose, CA) non-polar, wide pore polymer separation
  • FIG. 7 shows the effect on the chromatography result shown in FIG. 6 when Cr(lll) cations were added to the column before sample injection.
  • FIG. 8 shows the effect on the chromatography result of FIG. 7 when a Cr(lll) contaminated column was treated with EDTA prior to sample injection.
  • FIG 9. shows the chromatography of a 500 base pair DNA fragment on INERTSIL (MetaChem, Torrance, CA) C-18 non-polar, wide pore silica separation media which have been washed with EDTA to remove multivalent metal cations thereform.
  • INERTSIL MetalChem, Torrance, CA
  • FIG. 10 shows the effect on the chromatography result shown in FIG. 9
  • FIG. 11 shows the effect on the chromatography result of FIG. 10 when a Cr(lll) contaminated column was treated with EDTA prior to sample injection.
  • FIG .12 shows the chromatography of a 20 mer single stranded DNA fragment standard (Seq 2A, CTGen, Milpitas, CA) on INERTSIL (MetaChem, Torrance, CA) C-18 non-polar, wide pore silica separation media which have been washed with EDTA to remove multivalent metal cations thereform.
  • FIG. 13 shows the effect on the chromatography result shown in FIG. 12 when Cr(lll) cations were added to the column before sample injection.
  • FIG. 14 shows the chromatographic separation at 56 °C of a 209 base
  • DNA standard 4 component heteroduplex and homoduplex mixture on a freshly packed, untreated DNASep column (Transgenomic, Inc., San Jose, CA).
  • FIG. 15 shows the effect on the chromatography result shown in FIG 14 when the column was treated with EDTA prior sample injection.
  • polynucleotide as used herein, is defined as a linear polymer containing an indefinite number of nucleotides, linked from one ribose (or deoxyribose) to another via phosphate residues.
  • the present invention can be used in the separation of RNA or of double or single stranded DNA. For purposes of simplifying the description of the invention and not by way of limitation, the separation of double stranded DNA will be described hereinafter, it being understood that all polynucleotides are intended to be included within the scope of this invention.
  • the present invention is an improved chromatographic and batch process method for separating mixtures of polynucleotide fragments on wide pore non-polar separation media.
  • the improvement comprises ensuring the removal of all traces of residual multivalent metal cations from the sample mixture, the eluting solvent as well as components of the chromatographic or batch process equipment which contact said sample mixture and eluting solvent.
  • the system used to implement the method of the invention comprises a liquid chromatographic system.
  • the liquid chromatography system comprises a column containing a separation bed of non-polar, wide pore separation media held in the column between porous frits positioned at each end of the column.
  • Other components of the liquid chromatography system are also components of the liquid chromatography system.
  • Eluting solvent supply means is (are) connected to the injection valve, and the injection valve is connected to the inlet of the chromatographic separation column, by means of conduit (e.g., tubing), as illustrated in FIG. 5.
  • conduit e.g., tubing
  • the mixture of polynucleotide fragments is separated by Matched Ion Polynucleotide Chromatography (MIPC).
  • MIPC Matched Ion Polynucleotide Chromatography
  • MIPC Matched Ion Polynucleotide Chromatography
  • the pores of the separation media may be contiguous, i.e., extend from one surface of the media to another surface of the media.
  • the pores of the separation media may also be non-contiguous, i.e., extend into the media at one point on the surface but not through to another point on the surface.
  • the non-polar, wide pore separation media can be an inorganic substrate, including silica, zirconia, alumina, or other material; or can be polymeric, including crosslinked resins of polystyrene, polyacrylates, polyethylene, or other organic polymeric material.
  • the non-polar, wide pore separation media can also be a "rod column” or “monolith column”. Such columns contain silica or polymer separation media which have been formed inside the column as a continuous structure which has through pores or interstitial spaces which allow eluting solvent and analyte to pass through. The only requirement for the non-polar, wide pore separation media is that
  • non-polar, wide pore separation medium is defined to denote any material which has surface pores having a diameter that is greater than 30 Angstroms or the approximate size and shape of the smallest polynucleotide fragment in the separation in the solvent medium used therein or greater, and is capable of separating polynucleotide fragments.
  • the non-polar, wide pore separation medium may be any shape, those comprising alkylated wide pore polymer beads bead having an average diameter of 1-100 microns are preferred. Such particles are described in the references cited hereinbelow.
  • the separation media are washed with acid followed by methanol to ensure removal of residual multivalent cation contaminants.
  • the separation media can also be washed with EDTA or other chelating agent.
  • Non-polar, wide pore separation media and their use for the separation of polynucleotide mixtures are well known in the art and are commercially
  • Monolith or rod columns are commercially avialable form Merck & Co (Darmstadt, Germany) and described in the following references: U.S. Patent No. 5453185 to J. M. J. Frechet and F. Svec; M. Petro, et. al., Analytical Chemistry, 68, 315-321 (1996).
  • the references cited above and the references contained therein are incorporated in their entirety herein.
  • the components of the liquid chromatography system have surfaces (i.e., "process solution contacting surfaces") which contact process solutions held within the components (e.g., the eluting solvent supply means) or flowing through the components (e.g., the porous frits, chromatographic column, injection valve, and conduits).
  • process solution as used herein
  • process solution contacting surface refers to any surface of a liquid chromatography system which contacts said process solutions.
  • ⁇ J3 release multivalent cations into solutions flowing through the column, or collect said cations from other sources.
  • the material is preferably titanium, coated stainless steel, or organic polymer, or combinations thereof, but is most preferably acid treated titanium as described hereinbelow.
  • coated stainless steel refers to stainless steel that has been coated so that it does not release, or is prevented from releasing, multivalent cations.
  • a non-limiting example of a coating material is polytetrafluoroethylene (i.e., Teflon®).
  • Teflon® polytetrafluoroethylene
  • Coated stainless steel as used herein also refers to stainless steel that has been pre-treated with an agent such as EDTA or phosphoric acid which forms coordination complexes with multivalent metal ions.
  • Passivated stainless steel refers to stainless steel that has been treated with an agent that removes oxidized metals and also metals that are easily oxidized such as iron.
  • the most common passivating agent for stainless steel is nitric acid. Nitric acid will removed any oxidized metals, but will also remove iron that is located on the surface of the metal, leaving other metals such as chromium and nickel.
  • Some chelating agents can coat and passivate. EDTA will first coat oxidized metals especially colloidal iron oxide particles. As treatment continues, the EDTA will bind and dissolve the iron oxide. However, as individual iron molecules leave the particle, other chelating molecules must coat the newly exposed surfaces for the surface to
  • a chelating agent does not
  • a chelating agent may, eventually, dissolve oxidized metals.
  • the chelating agents used depend upon the type of ion contamination which is present. For example, Tiron chelating agent is selective for titanium and iron oxides. EDTA is selective for most metal oxides at pH 7.
  • Other chelating agents include cupferron, 8 hydroxyquinoline, oxine, and various iminodiacetic acid derivatives.
  • the metal ion chelate complex for example, EDTA-metal ion complex
  • the metal ion chelate complex is soluble in the fluid.
  • Chelating agents that form insoluble complexes for example 8- hydroxyquinoline, perform coating functions only.
  • oxidized and positively charged metals such as oxides of iron on the surface of stainless steel can trap negatively charged molecules such as DNA leading to degradation of the chromatographic separation, and that the pre-treatment masks or shields these surface charges.
  • EDTA can be added, for example, in an amount sufficient to shield any surface sites which would interfere with the chromatographic separation.
  • a solution of a metal chelating agent such as EDTA can be applied in a batch process to coat the surface, for example by a single injection of EDTA solution into the HPLC system.
  • EDTA is included as an additive in the eluting solvent in an amount sufficient to complex the metal ions present.
  • components of the liquid chromatography system are preferably titanium, coated stainless steel, or organic polymer such as polyetherether
  • the preferred eluting solvent inlet filters are composed of non-polar, porous,
  • non-stainless steel material which can be PEEK, polyethylene, or other polymeric material.
  • the preferred solvent pump is also made of a non- stainless steel material; the pump heads, check valves, and solvent filters are preferably titanium, PEEK, or other polymeric material.
  • the preferred means for removing oxygen from the eluting solvent is an inline degasser placed prior to the pump inlet.
  • the sample injection valve is also preferably titanium, PEEK, or other polymeric material.
  • a standard detector and eluting solvent reservoirs can be used, with no modifications necessary.
  • all of the process solution-contacting surfaces are subjected to a multivalent cation removal
  • a non-limiting example of a multivalent cation removal treatment is an acid wash treatment.
  • This wash treatment can include flushing or soaking and can include sonication.
  • An example of an acid wash treatment is
  • Other treatments include contacting the surfaces with chelating agents such as EDTA, pyrophosphoric acid, or phosphoric acid (e.g. 30% by weight phosphoric acid).
  • PEEK and titanium can be treated with dilute acids including nitric and hydrochloric acids.
  • PEEK is not compatible with concentrated sulfuric or concentrated nitric acids.
  • Titanium is not compatible with concentrated hot hydrochloric acid.
  • Treatment with a chelating agent can be performed before, but preferably after treatment with an acid. 20 mM tetrasodium EDTA is a preferred chelating agent treatment.
  • the preferred treatment for titanium frits is sonication for 10 minutes with cold hydrochloric acid, sonication with water until neutral pH, 2 hour sonication with 0.5 M tetrasodium EDTA, storage several days in 0.5 M tetrasodium EDTA, sonication with water until neutral pH, and then washing with methanol, followed by drying.
  • Preferred treatment for PEEK frits is sonication for 15-30 minutes each with THF, concentrated hydrochloric acid, 20% nitric acid, sonication with water until neutral pH, and then washing with
  • the ionic contaminant is organic, then organic solvents or a combination of
  • organic solvents and acids can be used. Also, organic ionic contaminants
  • Nonionic contaminants such as greases and oils will also contaminate the separation column, generally leading to poor peak shape, but depending upon the size of the fragment.
  • Nonionic organic contaminants such as oils will require detergents, soaps or surfactants to remove.
  • Column tubing can be treated under sonication with Decalin (D5039, Sigma) to remove silicon greases and oils. Removal of colloidal metal oxides such as colloidal iron oxide can require repeated or continuous treatment as the surface of the particle is dissolved and new metal oxides are exposed.
  • the preferred embodiment of the liquid chromatography system of the present invention utilizes methods to minimize the exposure of all process solution contacting surfaces to oxygen. Dissolved oxygen within the eluting
  • the liquid chromatography system preferably employs a degassing method for essentially removing dissolved oxygen from the eluting solvent prior to contact with the rest of the chromatography system.
  • degassing methods include sparging of the eluting solvent with an inert gas such as argon or helium, or filtering the eluting solvent under vacuum.
  • a preferred method uses a vacuum type degasser which employs inline
  • a stainless steel HPLC system can be used if a component for removing multivalent cations, herein referred to as a "multivalent cation capture resin," is also used.
  • a multivalent cation capture resin is preferably a cation exchange resin or chelating resin. Any suitable cation exchange resin or chelating resin can be used. Preferred cation exchange and chelating resins are described hereinbelow.
  • Cation exchange resins having an ion exchange moiety selected from the group consisting of iminodiacetate, nitriloacetate, acetylacetone, arsenazo, hydroxypyridinone, and 8-hydroxyquinoline groups are particularly preferred.
  • Cation exchange resins having hydroxypyridinone groups are especially useful for removing iron from the system.
  • Cation exchange resins having iminodiacetate groups are particularly preferred for use in the present invention because of their wide availability in resin format.
  • a chelating (i.e., coordination binding) resin is an organic compound which is capable of forming more than one non-covalent bond with a metal.
  • Chelating resins include iminodiacetate and crown ethers. Crown ethers are
  • cyclic oligomers of ethylene oxide which are able to interact strongly with alkali or alkaline earth cations and certain transition metal cations.
  • a cavity in the center of the molecule is lined with oxygen atoms which hold cations by electrostatic attraction.
  • Each ether has a strong preference for cations whose ionic radius best fits the cavity.
  • the multivalent cation capture resin is preferably contained in a guard
  • guard cartridge or guard disk.
  • Guard columns and cartridges are
  • the guard column or cartridge typically contain packing material which is similar to the stationary phase of the separation column.
  • the guard column or cartridge must contain a multivalent cation capture resin.
  • the guard disc or guard column must contain particles which trap the metal ions.
  • a preferred guard cartridge has a void volume of less than 5 mL, more
  • the preferred cartridge has a 10 x 3.2 mm bed volume.
  • guard disks are described in detail in U.S. Patent No. 5,338,448, which is incorporated herein by reference in its entirety.
  • a guard disk comprises a layer or pad of a multivalent
  • the guard disk is circular, having a rigid annular outer ring or collar for easy handling.
  • the annular ring can be constructed of any suitable material which is inert to the chromatographic separation, such as inert conventional engineering plastic. The only requirement for the material is that it must be inert to the eluting solvent and sample and have
  • guard disk material refers to a layer or pad of multivalent cation capture resin which has been incorporated
  • one or more pads of guard disk material 2 are
  • the fabric can be cut to a
  • the rigid annular outer ring can comprise two flanged rings, as shown in FIG. 2 and 3, an outer flanged ring 6 and an inner flanged
  • the inner flanged ring 8 is then inserted into the outer ring to form
  • the guard disk pad(s) is (are) frictionally held within the press-fit ring or collar.
  • the inner diameter (b) of the outer flanged ring and the inner diameter (a) of the inner flanged ring are substantially the same.
  • the rigid annular outer ring can be incorporated into the guard disk holder or chromatographic column cap.
  • the annular ring is a flange that is part of one or both sides of the disk holder or the column cap.
  • the guard disk does not have an outer ring.
  • a circle of the guard disk sheet material is placed into the holder or column cap.
  • the flange in the holder column cap is annular so that, when the holder or column cap is tightened, the flange pinches or seals the outer annular portion of the guard disk.
  • the center portion of the guard disk not pinched is in a chamber or depression in the holder or cap.
  • a multivalent cation capture resin contained in a guard column, guard cartridge, or guard disk is placed upstream of the separation column.
  • the guard column, cartridge, or disk containing the resin is placed upstream of the
  • a guard disk a guard cartridge or column can be used as long as the dead volume of the cartridge or column is not excessive and an effective eluting solvent gradient can be produced.
  • a guard disk, column, or cartridge can be placed before the injection valve and a second guard disk, column, or cartridge also placed between the sample injection valve and the separation column.
  • the second guard disk (or cartridge or column) can be avoided if the contaminants are sufficiently cleaned by a guard column placed upstream of the injection valve, or if the contaminants are avoided through the use of non- metal or titanium components throughout the HPLC system.
  • the eluting solvent reservoirs 12 contain eluting solvent inlet filters 14
  • solvent pump 16 is connected to a chelating column 20 by system tubing 18.
  • the chelating column 20 is connected to the sample injection valve 22 by
  • the sample injection valve has means for injecting a
  • the sample injection valve 22 is connected to a
  • the chelating guard disk 24 by system tubing 18.
  • the chelating guard disk 24 is
  • Detector 28 is connected to the separation column 26.
  • the system tubing, eluting solvent inlet filters, solvent pump, sample injection valve, and separation column are preferably made of titanium, coated stainless steel, or organic polymer.
  • the material is preferably treated so that it does not release multivalent cations.
  • the treatment can include treatment with nitric acid, phosphoric acid,
  • Detector 28 is located downstream from
  • FIG. 5 illustrates a specific embodiment of the invention in which a chelating guard disk is placed in direct contact with a titanium frit at the top
  • the column top 30 is adapted to receive the
  • solvent pump 46 pumps elution solvent to sample
  • transducer 50 which is electrically connected to a display device 52.
  • a chelating guard column, cartridge, or disk can be used in conjunction with a conventional, stainless steel liquid chromatography system, or with a system containing non-metal or titanium
  • washing solvents comprise tetrahydrofuran, hydrochloric acid, and water.
  • An example of a preferred washing procedure is described in Examplel .
  • the methods of the invention comprise using the improved systems described above to separate mixtures of polynucleotide fragments, particularly double-stranded polynucleotide fragments.
  • the methods of the present invention can be used to separate polynucleotide fragments having up to about 1500 base pairs using non-polar, wide pore separation media under the chromatography conditions described herein.
  • the most preferred method of the invention comprises contacting a
  • a guard cartridge or guard column containing multivalent cation capture resin is placed at the front of the column or in line between the eluting
  • the polynucleotide fragments are separated by releasing said fragments from the separation media using an eluting solvent comprising an organic component, water, and a counterion agent.
  • the separation of the polynucleotide components is based on the size or polarity of the fragments.
  • the fragments are released from the separation media in order of size by increasing the concentration of organic component in the eluting solvent.
  • the concentration of the organic component can be increased in stepwise fashion by means of a step gradient, or continuously, by means of a continuous gradient.
  • non-polar, wide pore silica and polymer separation media is presented in Examples 2 - 7 and FIGs. 6 - 15.
  • Example 2 describes a polynucleotide fragment separation on non- polar, wide pore organic polymer separation media using the optimized
  • Example 3 is identical to Example 2, except that non-polar, wide pore silica separation media were used in the chromatography.
  • Example 4 a series of three separations of a 500 base pair DNA fragment was performed using non-polar, wide pore polymer separation media are described. In the first separation, the separation media was
  • Example 5 describes an sequence similar to Example 4, except that non-polar, wide pore silica separation media was used and washed with EDTA solution prior to sample injection. Once again, a sharp sample peak
  • Example 6 chromatographic separation of a 20 mer single stranded DNA standard is described in Example 6 and shown by the complete loss of resolution as seen in FIG. 13 (after deliberate Cr (III) contamination) compared to FIG. 12 (column cleaned with EDTA).
  • a standard 4 component mixture of double stranded DNA consisting of two 209 base pair homoduplex fragments and two 209 base pair
  • heteroduplex fragments were chromatographed at 56 °C as described in
  • Example 6 on a freshly packed column DNASep column (Transgenomic, Inc., San Jose, CA).
  • FIG. 14 shows only partial resolution of the 4 component mixture.
  • EDTA solution when the column was treated with EDTA solution followed by re-injection and elution of the 4 component homoduplex/heteroduplex DNA mixture as described in Example 6, a clean separation of all 4 components was achieved, as seen in FIG. 15.
  • This result clearly indicates that trace levels of multivalent cations were present in a freshly packed column, and that said cations interfered with the separation of double stranded DNA fragments.
  • the method of the invention can also be used to separate
  • polynucleotide mixtures in a batch process useful for production and isolation of pure polynucleotide fragments of a plurality of selected sizes, on a small or
  • the method of the invention comprises contacting a solution of a
  • the separation media are held in a container.
  • the container may be a column, a membrane, a container, or a
  • the polynucleotide mixture is held on the separation media since the concentration of the organic component of the solvent in which the mixture is dissolved is not sufficient to release the polynucleotide fragments therefrom.
  • the separation media are then contacted with a first eluting solvent and a counterion agent, said first eluting solvent having a concentration of the organic component sufficient to remove all polynucleotide fragments from the separation media which are smaller than the selected size.
  • the eluting solvent is then separated from the separation media.
  • the separation media are rinsed with the first eluting solvent to remove any remaining released polynucleotides.
  • the separation media are then contacted with a second eluting solvent and counterion agent, said second eluting solvent having a concentration of the organic component sufficient to release the polynucleotide fragment having the selected size from the separation media.
  • the second eluting solvent is separated from the separation media and the particles are rinsed with the second eluting solvent. This process can be repeated to release polynucleotide of any selected size which are present in the mixture.
  • fragments of any specific base pair length can be determined experimentally. For example, isolation of a 102 base pair fragment from the polynucleotide mixture may be desired, and said fragment may be eluted with 15.9%
  • the separation media holding the polynucleotide mixture may be contacted with
  • Non-polar, wide pore separation media and their use for the separation of polynucleotide mixtures are well known in the art and are commercially available, e.g., Hamilton HPLC Application Handbook, (1993), Hamilton Company, Inc., 4970 Energy Way, Reno, Nevada 89502. This, and references contained therein, are incorporated in their entirety herein.
  • Another reference, which is incorporated in its entirety herein, describing polynucleotide separations on non-polar, wide pore reverse phase particles is Chromatography, 5 th edition, Part B, edited by E. Heftmann, Elsevier (1992). Separation of tRNA and DNA fragment mixtures on non-polar, wide pore silica particles is described by R. Bischoff and L.W.
  • the non-polar, wide pore reverse phase separation media were washed three times with tetrahydrofuran, then two times with methanol.
  • the non-polar, wide pore separation media were then stirred for 12 hours with a mixture containing 100 mL of tetrahydrofuran and 100 mL of concentrated hydrochloric acid.
  • the non-polar, wide pore separation media were washed with tetrahydrofuran/water (1 :1) until neutral
  • Non-polar, Wide pore Polymer Separation Media Non-polar, wide pore PRX-1 separation media (Sarasep, Inc. San Jose, CA.) of polystyrene/divinylbenzene polymer having a pore size of 50 - 200 Angstroms (average pore size is 80 Angstroms) and a bead diameter of 5 microns are washed as described in Example 1 and packed in a 4.6 x 50 mm
  • the flow rate is 0.75 mL/min, UV detection at 260 nm, column temp.
  • colloidal iron suspension is injected onto the column and allowed to stand for
  • INERTSIL MetalChem, Torrance, CA
  • Example 4 Standard Procedure for Demonstrating the Effects of Chromium(lll) On The Separation of Double Stranded DNA Using Non-polar, Wide Pore
  • Non-polar, wide pore PRX-1 separation media (Sarasep, Inc., San
  • Example 2 a pore size of 50 - 200Angstroms (80 Angstrom average pore size) was washed as described in Example 1 and packed in 4.6 x 50 mm HPLC column.
  • the flow rate was 0.60 mL/min, UV detection at 260 nm, column
  • a 520 ppm aqueous solution of Cr(lll) was prepared from Cr 3 (S0 4 ) 2 .
  • Example 4 showed a peak (FIG. 11)corresponding to the 500 base pair DNA standard
  • Example 5 Using Non-polar, Wide Pore Silica Separation Media The column described in Example 5 was cleaned with Na 4 EDTA as decribed in Example 5 and equilibrated with 60%A eluting solvent to a constant bse line. A 20 mer, single stranded DNA standard (Seq2A purchased from CTGen, Milpitas, CA) was injected onto the column and eluted with the gradient protocol of Example 4.
  • FIG 12 shows a major peak corresponding to the 20 mer standard and some well resolved impurity peaks.
  • Example 4 A single 5 mL injection of the Cr(lll) solution described in Example 4 was followed by re-injection of the 20 mer standard and elution using the gradient protocol of Example 4. The results seen in FIG. 13 show a greatly diminished peak corresponding to the 20 mer, and essentially no resolution of the impurities.
  • a freshly packed DNASep column (Transgenomic, Inc., San Jose, CA) was equilibrated with eluting solvent 50%A.
  • a mixture of DNA 209 base pair standard fragments (Transgenomic, Inc., San Jose, CA, Cat. No. 560012) consisting of 2 heteroduplex DNA fragmetns and 2 homoduplex DNA fragments was injected (5 ⁇ L) onto the column. The mixture was eluted at a
  • FIG. 14 shows the results of a chromatography run at 56 °C, on a
  • cation contamination is more critical at higher column temperatures, especially as related to the difficult separation of homoduplex and heteroduplex fragments of identical base pair length.

Abstract

The invention recognizes the deleterious effects of trace, and even undetectable amounts of multivalent cations on the separation of mixtures of polynucleotides, especially double stranded polynucleotides, and provides an improved method for separating such mixtures on wide pore, non-polar separation media by eliminating multivalent cations from the all aspects of the separation process. This is accomplished by using components in the separation process which are materials which do not release metal cations. In addition, the use of cation capture resins and other methods to remove residual traces of multivalent cations from eluting solvents, sample solutions, separation media, and system components is described. It is also important to remove any traces or organic contaminants from solvents solutions and system parts. Taking similar steps to remove residual traces of multivalent cations and organic impurities from the separation process, the invention may also be used in a batch process to separate mixtures of polynucleotides fragments.

Description

IMPROVED PROCESS FOR PERFORMING POLYNUCLEOTIDE
SEPARATIONS
FIELD OF THE INVENTION
This invention is directed to the separation of polynucleotide fragments by liquid chromatography. More specifically, the invention is directed to a system and method, which enhances the chromatographic separation of polynucleotides on non-polar, wide pore separation media.
BACKGROUND OF THE INVENTION
Separation of polynucleotide mixtures is a focus of scientific interest, and numerous researchers have been attempting to achieve technical improvements in various aspects of polynucleotide separation. Anion exchange separation and reverse phase ion pair chromatography are among the most frequently used methods for separating polynucleotide mixtures. Samples containing mixtures of polynucleotides can result from total synthesis of polynucleotides, cleavage of DNA with restriction endonucleases or RNA, as well as polynucleotide samples which have been multiplied or amplified using polymerase chain reaction (PCR) techniques or other amplifying techniques.
Previous work has focused on developing rapid, high resolution
separations, developing separations based on the size of the polynucleotide fragment rather than the base sequence of the fragment, and on developing the ability to collect separated pure fractions of polynucleotides. W. Bloch (European patent publication No. EP 0 507 591 A2) demonstrated that, to a certain extent, length-relevant separation of polynucleotide fragments was possible on nonporous anion exchanger separation media using eluting solvents containing tetramethylammonium
chloride (TMAC). Y. Ohimya et al. (Anal. Biochem., 189:126-130 (1990))
disclosed a method for separating polynucleotide fragments on anion exchange material carrying trimethylammonium groups. Anion exchangers with diethylaminoethyl groups were used by Y. Kato et al. to separate
polynucleotide fragments (J. Chromatogr., 478:264 (1989)).
U.S. Patent No. 5,585,236 (1996) to Bonn et al. describes a method for separating polynucleotides using what was characterized as reverse phase ion pair chromatography (RPIPC) utilizing columns filled with non-polar, nonporous polymeric beads. High resolution, rapid separations were achieved using an ion pairing agent (triethylammonium acetate), and acetonitrile/water eluting solvent gradient. This work is important because it is the first example of a size dependent, sequence independent chromatographic separation of double-stranded polynucleotides by Matched Ion Polynucleotide Chromatography (MIPC). Such separations are comparable to those effected by gel electrophoresis, which is currently the technology most widely used for polynucleotide separations. Bonn's work makes it possible to automate separations of polynucleotides based on their
size alone. This method differs from traditional reverse phase processes.
Therefore, the term Matched Ion Polynucleotide Chromatography (MIPC) has
been applied to the Bonn process to distinguish it from previously known
reverse phase processes. The invention of parent application Serial No. 08/748,376 is based on the discovery that trace levels of multivalent metal ions, even when present below the limits of detection, interfere with the MIPC separation process. Special steps to prevent, remove or complex any trace multivalent ions result in enhanced separation of polynucleotides and lower the detection threshold. The inventions of provisional applications Serial No. 60/049,123 filed June 10,
1997; and Serial No. 60/063,835 filed October 30, 1997 under 35 U.S.C. §111 (b) are based on the discovery that nitric acid passivated stainless steel, titanium, and PEEK (polyetherether ketone) surfaces were, contrary to popular belief, sources of multivalent metal ion contamination in the MIPC process. The deleterious effect of multivalent metal cations on polynucleotide separations as observed herein has not been previously reported. We believe that all chromatographic processes which are capable of separating polynucleotides on non-polar, wide pore separation media are impaired by the interference of multivalent metal ions.
SUMMARY OF THE INVENTION
Therefore, the invention provides an improved method for separating a mixture of polynucleotide fragments wherein multivalent cations are eliminated from the all aspects of the separation process. The method comprises applying a solution of said fragments and counterion agent to a column containing separation media having a non-polar surface, wherein said
separation media have a pore size greater than 30 Angstroms and an
average diameter of 1-100 microns. Separation of said fragments is
accomplished by eluting said fragments with an eluting solvent gradient of increasing organic component concentration containing a counterion agent. Surfaces which are contacted by the solution of the fragments and the eluting solvent are materials which do not release multivalent metal cations therefrom, said materials having been washed to remove traces of organic contaminants therefrom. The method further comprises contacting the solution of said fragments and the eluting solvent with a multivalent cation capture resin to remove any multivalent cations therein before entering the column.
In a preferred embodiment of the invention, the separation media have
been treated to remove residual traces of multivalent cations from the surfaces therefrom.
An optimum embodiment of the invention comprises contacting the solution of said fragments and eluting solvent with a multivalent cation capture resin before entering the column, treating the separation media to remove residual traces of multivalent cations from the surfaces therefrom, and ensuring that surfaces which are contacted by the solution of the fragments and the eluting solvent are materials which do not release
multivalent metal cations therefrom and cleaning said surfaces to remove any
traces of organic contaminants therefrom. In one embodiment, the polynucleotide fragments are double stranded, having more than 5 base pairs. Such fragments are separated by size or by polarity.
In another embodiment of the invention, the polynucleotide fragments are single stranded having 2 or more nucleotides. Such fragments are separated by size and by polarity. The separation media are organic polymer, or an inorganic substrate selected from the group consisting of inorganic substrates, silica, zirconia, and alumina. The inorganic substrates support a non-polar material on their surface. Said non-polar material may be organic polymer or long chain, C1 to C24 hydrocarbon groups bound to the inorganic substrate, wherein residual polar groups of the substrate are end capped with trimethylsilyl chloride or
hexamethyldisilazane.
In a preferred embodiment, surfaces which are contacted by the solution of polynucleotide fragments and eluting solvent are titanium, coated stainless steel, organic polymer or combinations thereof. Removal of traces of residual multivalent metal cations from the separation process is further ensured by treating said surfaces with a solution comprising aqueous acid and chelating agent, by adding a chelating agent to the solution of polynucleotide mixture and eluting solvent, and by treating the eluting solvent to remove oxygen therefrom.
In one embodiment, the improved method for separating said mixture of polynucleotides comprises Matched Ion Polynucleotide Chromatography.
The improved method of the invention may also be practiced as a
batch process for separating polynucleotide fragments having a selected size from a mixture of polynucleotide fragments including fragments of said selected size. The batch process method of the invention comprises applying
a solution of said polynucleotide fragments and a counterion agent to non- polar separation media having a non-polar surface, wherein said separation media have a pore size greater than 30 Angstroms and an average diameter of 1-100 microns. The method further comprises contacting the separation media with a first eluting solvent and counterion agent, the first eluting solvent having a concentration of organic component sufficient to release from the separation media all polynucleotide fragments having a size smaller than the selected size and removing the first eluting solvent from the separation media. The selected size fragments are obtained by contacting the separation media with a second eluting solvent having a concentration of organic component sufficient to release from the separation media the polynucleotide fragments having the selected size and removing the second eluting solvent from the separation media. Preferably, surfaces which are contacted by the solution of polynucleotide fragments and the eluting solvent are material which does not release multivalent metal cations therefrom.
Following removal of the first eluting solvent, the separation media are rinsed with fresh first eluting solvent to remove residual released polynucleotide fragments therefrom. In a similar manner, following removal of the second eluting solvent the separation media are rinsed with fresh second eluting solvent to remove residual released polynucleotide fragments of selected size therefrom.
A preferred embodiment of the invention comprises contacting the solution of polynucleotide mixture and eluting solvent with a multivalent cation capture resin before contacting the separation media. In another preferred
embodiment the method comprises treating the separation media to remove residual traces of multivalent cations therefrom. Optimally the separation
media have been treated to remove residual traces of multivalent cations therefrom and the solution of polynucleotide mixture and eluting solvent have been contacted with a multivalent cation capture resin before contacting the separation media. Said separation media are contained in a column, a web, a membrane, or container.
The batch process can be used to separate mixtures of double stranded polynucleotides or single stranded polynucleotides. The separation media are organic polymer, or an inorganic substrate selected from the group consisting of inorganic substrates, silica, zirconia, and alumina. The inorganic substrates support a non-polar material on their surface. Said non-polar material may be organic polymer or long chain, C1 to C24 hydrocarbon groups bound to the inorganic substrate, wherein residual polar groups of the substrate are end capped with trimethylsilyl chloride or hexamethyldisilazane.
The surfaces contacted by the solution of polynucleotide fragments and eluting solvent are, preferably, comprised of material selected from the group consisting of titanium, coated stainless steel, and organic polymer, or combinations thereof. Removal of traces of residual multivalent metal cations from the separation process is further ensured by treating said surfaces with a solution comprising aqueous acid and chelating agent, by adding a chelating agent to the solution of polynucleotide mixture and eluting solvent, and by treating the eluting solvent to remove oxygen therefrom.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows a guard disk having a one-piece annular ring.
FIG. 2 is an exploded view of a guard disk having a two-piece annular
ring and containing three pads of guard disk material (i.e., a layer or pad of multivalent cation capture resin which has been incorporated into a fabric or membrane).
FIG. 3 shows an assembled view of the guard disk of FIG. 2. FIG. 4 shows placement of a chelating guard column and chelating guard disk in a liquid chromatographic system for polynucleotide separation. FIG. 5 shows placement of a chelating guard disk positioned between a chromatographic separation column and a column top, where the guard disk is in direct contact with a titanium frit at the top portion of the separation column. FIG 6. shows the chromatography of a 500 base pair DNA fragment on
PRX-1 (Sarasep, San Jose, CA) non-polar, wide pore polymer separation
media which have been washed (see Example 1 ) to remove multivalent metal cations thereform.
FIG. 7 shows the effect on the chromatography result shown in FIG. 6 when Cr(lll) cations were added to the column before sample injection.
FIG. 8 shows the effect on the chromatography result of FIG. 7 when a Cr(lll) contaminated column was treated with EDTA prior to sample injection. FIG 9. shows the chromatography of a 500 base pair DNA fragment on INERTSIL (MetaChem, Torrance, CA) C-18 non-polar, wide pore silica separation media which have been washed with EDTA to remove multivalent metal cations thereform.
FIG. 10 shows the effect on the chromatography result shown in FIG. 9
when Cr(lll) cations were added to the column before sample injection. FIG. 11 shows the effect on the chromatography result of FIG. 10 when a Cr(lll) contaminated column was treated with EDTA prior to sample injection.
FIG .12 shows the chromatography of a 20 mer single stranded DNA fragment standard (Seq 2A, CTGen, Milpitas, CA) on INERTSIL (MetaChem, Torrance, CA) C-18 non-polar, wide pore silica separation media which have been washed with EDTA to remove multivalent metal cations thereform.
FIG. 13 shows the effect on the chromatography result shown in FIG. 12 when Cr(lll) cations were added to the column before sample injection.
FIG. 14 shows the chromatographic separation at 56 °C of a 209 base
pair DNA standard 4 component heteroduplex and homoduplex mixture on a freshly packed, untreated DNASep column (Transgenomic, Inc., San Jose, CA).
FIG. 15 shows the effect on the chromatography result shown in FIG 14 when the column was treated with EDTA prior sample injection.
DETAILED DESCRIPTION OF THE INVENTION
The term polynucleotide, as used herein, is defined as a linear polymer containing an indefinite number of nucleotides, linked from one ribose (or deoxyribose) to another via phosphate residues. The present invention can be used in the separation of RNA or of double or single stranded DNA. For purposes of simplifying the description of the invention and not by way of limitation, the separation of double stranded DNA will be described hereinafter, it being understood that all polynucleotides are intended to be included within the scope of this invention.
The present invention is an improved chromatographic and batch process method for separating mixtures of polynucleotide fragments on wide pore non-polar separation media. The improvement comprises ensuring the removal of all traces of residual multivalent metal cations from the sample mixture, the eluting solvent as well as components of the chromatographic or batch process equipment which contact said sample mixture and eluting solvent. The inventor's observation and demonstration that even traces of multivalent metal cations below the level of detection, degrade polynucleotide separations on wide pore, non-polar separation media and that removal of said cations results in improved separation efficiency and column life is both surprising and novel.
The system used to implement the method of the invention comprises a liquid chromatographic system. The liquid chromatography system comprises a column containing a separation bed of non-polar, wide pore separation media held in the column between porous frits positioned at each end of the column. Other components of the liquid chromatography system
include an injection valve and one or more eluting solvent supply means. Eluting solvent supply means is (are) connected to the injection valve, and the injection valve is connected to the inlet of the chromatographic separation column, by means of conduit (e.g., tubing), as illustrated in FIG. 5.
The chromatography system components mentioned hereinabove and variations thereof are well known in the chromatography art and described in detail in references cited hereinbelow.
λo In a preferred embodiment of the invention, the mixture of polynucleotide fragments is separated by Matched Ion Polynucleotide Chromatography (MIPC). The term "Matched Ion Polynucleotide Chromatography" as used herein is defined as a process for separating single and double stranded polynucleotides using non-polar, wide pore separation media, wherein the process uses a counterion agent, and an organic solvent to release the polynucleotides from the separation media.
The pores of the separation media may be contiguous, i.e., extend from one surface of the media to another surface of the media. The pores of the separation media may also be non-contiguous, i.e., extend into the media at one point on the surface but not through to another point on the surface.
The non-polar, wide pore separation media can be an inorganic substrate, including silica, zirconia, alumina, or other material; or can be polymeric, including crosslinked resins of polystyrene, polyacrylates, polyethylene, or other organic polymeric material. The non-polar, wide pore separation media can also be a "rod column" or "monolith column". Such columns contain silica or polymer separation media which have been formed inside the column as a continuous structure which has through pores or interstitial spaces which allow eluting solvent and analyte to pass through. The only requirement for the non-polar, wide pore separation media is that
they must have a surface that is either intrinsically hydrophobic or be bonded
with a material that forms a surface having sufficient hydrophobicity to interact with a counterion agent.
As used herein, the term "non-polar, wide pore separation medium" is defined to denote any material which has surface pores having a diameter that is greater than 30 Angstroms or the approximate size and shape of the smallest polynucleotide fragment in the separation in the solvent medium used therein or greater, and is capable of separating polynucleotide fragments. Although the non-polar, wide pore separation medium may be any shape, those comprising alkylated wide pore polymer beads bead having an average diameter of 1-100 microns are preferred. Such particles are described in the references cited hereinbelow.
Regardless of the source or composition of the non-polar, wide pore reverse phase separation media described above, special precautions are taken to ensure that they are substantially free of multivalent cation contaminants. For example, the separation media are washed with acid followed by methanol to ensure removal of residual multivalent cation contaminants. The separation media can also be washed with EDTA or other chelating agent. The concepts, materials, systems and methods related to chromatography on non-polar, wide pore separation media are well known and are described in detail in the following references: Chromatography
Today, by Colin F. Poole and Salwa K. Pool, Elsevier (1991); Introduction to Modern Liquid Chromatography, L. R. Snyder and J. J. Kirland, J. Wiley and Sons, Inc. (1979). These references and references contained therein are incorporated in their entirety herein.
Non-polar, wide pore separation media and their use for the separation of polynucleotide mixtures are well known in the art and are commercially
available, e.g., Hamilton HPLC Application Handbook, (1993), Hamilton
Company, Inc., 4970 Energy Way, Reno, Nevada 89502. This, and
ΛZ references contained therein, are incorporated in their entirety herein. Another reference, which is incorporated in its entirety herein, describing polynucleotide separations on non-polar, wide pore separation media is Chromatography, 5th edition, Part B, edited by E. Heftmann, Elsevier (1992). Separation of tRNA and DNA fragment mixtures on non-polar, wide pore silica particles is described by R. Bischoff and L.W. McLaughlin, Analytical Biochemistry, 155, 526-533 (1985) and S. Eriksson, et. al., J.
Chromatography, 359. 265-274 (1986).
Monolith or rod columns are commercially avialable form Merck & Co (Darmstadt, Germany) and described in the following references: U.S. Patent No. 5453185 to J. M. J. Frechet and F. Svec; M. Petro, et. al., Analytical Chemistry, 68, 315-321 (1996). The references cited above and the references contained therein are incorporated in their entirety herein.
The components of the liquid chromatography system have surfaces (i.e., "process solution contacting surfaces") which contact process solutions held within the components (e.g., the eluting solvent supply means) or flowing through the components (e.g., the porous frits, chromatographic column, injection valve, and conduits). The term "process solution" as used herein
refers to any solution (such as the polynucleotide mixture solution and the eluting solvent) which is contained within or flows through any component of the liquid chromatography system during the chromatographic process. The term "process solution contacting surface" refers to any surface of a liquid chromatography system which contacts said process solutions.
The process solution contacting surfaces of the porous frits on either end of the separation column must be made of material which does not
■J3 release multivalent cations into solutions flowing through the column, or collect said cations from other sources. The material is preferably titanium, coated stainless steel, or organic polymer, or combinations thereof, but is most preferably acid treated titanium as described hereinbelow. The term "coated stainless steel" as used herein refers to stainless steel that has been coated so that it does not release, or is prevented from releasing, multivalent cations. A non-limiting example of a coating material is polytetrafluoroethylene (i.e., Teflon®). "Coated stainless steel" as used herein also refers to stainless steel that has been pre-treated with an agent such as EDTA or phosphoric acid which forms coordination complexes with multivalent metal ions.
"Passivated stainless steel" as used herein refers to stainless steel that has been treated with an agent that removes oxidized metals and also metals that are easily oxidized such as iron. The most common passivating agent for stainless steel is nitric acid. Nitric acid will removed any oxidized metals, but will also remove iron that is located on the surface of the metal, leaving other metals such as chromium and nickel. Some chelating agents can coat and passivate. EDTA will first coat oxidized metals especially colloidal iron oxide particles. As treatment continues, the EDTA will bind and dissolve the iron oxide. However, as individual iron molecules leave the particle, other chelating molecules must coat the newly exposed surfaces for the surface to
remain suitable for polynucleotide separations. A chelating agent does not
passivate in the sense that it will only coat metal ions for which it is specific and will not dissolve non-oxidized metals. However, a chelating agent may, eventually, dissolve oxidized metals. The chelating agents used depend upon the type of ion contamination which is present. For example, Tiron chelating agent is selective for titanium and iron oxides. EDTA is selective for most metal oxides at pH 7. Other chelating agents include cupferron, 8 hydroxyquinoline, oxine, and various iminodiacetic acid derivatives. If the chelating agents are to be used as passivating reagents as well as coating reagents, then it is important that the metal ion chelate complex, for example, EDTA-metal ion complex, is soluble in the fluid. Chelating agents that form insoluble complexes, for example 8- hydroxyquinoline, perform coating functions only. Without wishing to be bound by theory, it is believed that oxidized and positively charged metals, such as oxides of iron on the surface of stainless steel can trap negatively charged molecules such as DNA leading to degradation of the chromatographic separation, and that the pre-treatment masks or shields these surface charges. EDTA can be added, for example, in an amount sufficient to shield any surface sites which would interfere with the chromatographic separation. In one embodiment, a solution of a metal chelating agent such as EDTA can be applied in a batch process to coat the surface, for example by a single injection of EDTA solution into the HPLC system. In another embodiment, EDTA is included as an additive in the eluting solvent in an amount sufficient to complex the metal ions present.
Other components of the liquid chromatography system are preferably titanium, coated stainless steel, or organic polymer such as polyetherether
ketone (PEEK) or polyethylene. The preferred system tubing (i.e., conduit) is
titanium, PEEK, or other polymeric material, with an inner diameter of 0.007".
The preferred eluting solvent inlet filters are composed of non-polar, porous,
5 non-stainless steel material, which can be PEEK, polyethylene, or other polymeric material. The preferred solvent pump is also made of a non- stainless steel material; the pump heads, check valves, and solvent filters are preferably titanium, PEEK, or other polymeric material. The preferred means for removing oxygen from the eluting solvent is an inline degasser placed prior to the pump inlet. The sample injection valve is also preferably titanium, PEEK, or other polymeric material. A standard detector and eluting solvent reservoirs can be used, with no modifications necessary.
Materials such as titanium, PEEK and other organic polymers such as polyethylene, have been generally considered to be inert and preferred for the chromatographic separation of biological molecules. We have discovered that these materials, while inert for the prior art processes, can be a source of contaminants which interfere with the chromatographic separation of polynucleotides on non-polar, wide pore separation media. We have also observed that the interference with separation of polynucleotides by these materials becomes more apparent during separations carried out at elevated temperatures, e.g. 56 °C as compared to 50 °C.
In a preferred embodiment of the present invention, all of the process solution-contacting surfaces are subjected to a multivalent cation removal
treatment to remove any potential source of multivalent cation contamination. These surfaces include the column inner surface, porous frits, conduits, eluting solvent supply system, injector valves, mixers, pump heads, and fittings. A non-limiting example of a multivalent cation removal treatment is an acid wash treatment. This wash treatment can include flushing or soaking and can include sonication. An example of an acid wash treatment is
A sonication of a PEEK or titanium frit in the presence of aqueous nitric acid solution, followed by sonication in water until a neutral pH is achieved. Other treatments include contacting the surfaces with chelating agents such as EDTA, pyrophosphoric acid, or phosphoric acid (e.g. 30% by weight phosphoric acid).
PEEK and titanium can be treated with dilute acids including nitric and hydrochloric acids. PEEK is not compatible with concentrated sulfuric or concentrated nitric acids. Titanium is not compatible with concentrated hot hydrochloric acid. Treatment with a chelating agent can be performed before, but preferably after treatment with an acid. 20 mM tetrasodium EDTA is a preferred chelating agent treatment.
The preferred treatment for titanium frits is sonication for 10 minutes with cold hydrochloric acid, sonication with water until neutral pH, 2 hour sonication with 0.5 M tetrasodium EDTA, storage several days in 0.5 M tetrasodium EDTA, sonication with water until neutral pH, and then washing with methanol, followed by drying. Preferred treatment for PEEK frits is sonication for 15-30 minutes each with THF, concentrated hydrochloric acid, 20% nitric acid, sonication with water until neutral pH, and then washing with
methanol, followed by drying. Although this is a preferred treatment method, the effectiveness of this treatment of PEEK frits can depend on the vendor and lot of material treated. The success of the treatment also depends on the temperature of the polynucleotide separation with higher column
temperatures requiring the most complete removal of contamination. If the ionic contaminant is organic, then organic solvents or a combination of
organic solvents and acids can be used. Also, organic ionic contaminants
j can require detergents, soaps or surfactants for removal from the surface. Nonionic contaminants such as greases and oils will also contaminate the separation column, generally leading to poor peak shape, but depending upon the size of the fragment. Nonionic organic contaminants such as oils will require detergents, soaps or surfactants to remove. Column tubing can be treated under sonication with Decalin (D5039, Sigma) to remove silicon greases and oils. Removal of colloidal metal oxides such as colloidal iron oxide can require repeated or continuous treatment as the surface of the particle is dissolved and new metal oxides are exposed. The preferred embodiment of the liquid chromatography system of the present invention utilizes methods to minimize the exposure of all process solution contacting surfaces to oxygen. Dissolved oxygen within the eluting
solvent, for example, can react with exposed metals on these surfaces to form oxides which will interfere with the chromatographic separation. The liquid chromatography system preferably employs a degassing method for essentially removing dissolved oxygen from the eluting solvent prior to contact with the rest of the chromatography system. Examples of degassing methods include sparging of the eluting solvent with an inert gas such as argon or helium, or filtering the eluting solvent under vacuum. A preferred method uses a vacuum type degasser which employs inline
passage of the eluting solvent over one side of an oxygen permeable membrane system where the other side is subjected to a vacuum. An
example of a suitable four channel vacuum type degasser is Degaset™,
Model 6324 (MetaChem Technologies, Torrance, CA).
AS In another embodiment of the invention, a stainless steel HPLC system can be used if a component for removing multivalent cations, herein referred to as a "multivalent cation capture resin," is also used. A multivalent cation capture resin is preferably a cation exchange resin or chelating resin. Any suitable cation exchange resin or chelating resin can be used. Preferred cation exchange and chelating resins are described hereinbelow.
Cation exchange resins having an ion exchange moiety selected from the group consisting of iminodiacetate, nitriloacetate, acetylacetone, arsenazo, hydroxypyridinone, and 8-hydroxyquinoline groups are particularly preferred. Cation exchange resins having hydroxypyridinone groups are especially useful for removing iron from the system. Cation exchange resins having iminodiacetate groups are particularly preferred for use in the present invention because of their wide availability in resin format.
A chelating (i.e., coordination binding) resin is an organic compound which is capable of forming more than one non-covalent bond with a metal. Chelating resins include iminodiacetate and crown ethers. Crown ethers are
cyclic oligomers of ethylene oxide which are able to interact strongly with alkali or alkaline earth cations and certain transition metal cations. A cavity in the center of the molecule is lined with oxygen atoms which hold cations by electrostatic attraction. Each ether has a strong preference for cations whose ionic radius best fits the cavity.
The multivalent cation capture resin is preferably contained in a guard
column, guard cartridge, or guard disk. Guard columns and cartridges are
frequently used to protect liquid chromatography columns from contamination
and are widely available. In their normal use, guard columns and cartridges
-fS typically contain packing material which is similar to the stationary phase of the separation column. However, for use in the present invention, the guard column or cartridge must contain a multivalent cation capture resin. The guard disc or guard column must contain particles which trap the metal ions. For use in the system of the present invention, the guard cartridge or
column should be sufficiently large to provide adequate cation capture capacity, but must be small enough to allow effective gradient elution to be used. A preferred guard cartridge has a void volume of less than 5 mL, more
preferably, less than 1 mL, so that the eluting solvent gradient is not delayed by more than 5 minutes and, preferably, less than 1 minute. The preferred cartridge has a 10 x 3.2 mm bed volume.
Guard disks are described in detail in U.S. Patent No. 5,338,448, which is incorporated herein by reference in its entirety. For use in the present invention, a guard disk comprises a layer or pad of a multivalent
cation capture resin which has been incorporated into a fabric or membrane so that the resin is not separable from the guard disk under liquid flow
conditions present during the performance of chromatographic separations. In its preferred form, the guard disk is circular, having a rigid annular outer ring or collar for easy handling. The annular ring can be constructed of any suitable material which is inert to the chromatographic separation, such as inert conventional engineering plastic. The only requirement for the material is that it must be inert to the eluting solvent and sample and have
sufficient dimensional stability. The rigid annular outer ring of the guard disk
can comprise a single rigid annular outer ring encircling a disk-shaped pad of
guard disk material. As used herein, the term "guard disk material" refers to a layer or pad of multivalent cation capture resin which has been incorporated
into a fabric or membrane.
As shown in FIG. 1 , one or more pads of guard disk material 2 are
placed in the rigid annular ring 4. For example, the fabric can be cut to a
circular diameter which securely contacts the inner diameter surface of the annular ring. As the disk holder is tightened against the disk, the top and bottom surfaces of the holder seal against the collar of the guard disk. Sealing pressure from the guard disk holder is, therefore, applied against the collar of the disk which prevents the material of the guard disk pad from being crushed.
Alternatively, the rigid annular outer ring can comprise two flanged rings, as shown in FIG. 2 and 3, an outer flanged ring 6 and an inner flanged
ring 8, where the inner flanged ring is insertable within the flange of the outer
ring, forming a press-fit two-piece collar around one or more pads of guard disk material 10. Preferably, the inner diameter (a) of the inner flanged ring
will have the same diameter as the separation column bed.
In the two-piece annular ring embodiment shown in FIG. 3, one or
more pads of guard disk material 10 having a diameter greater than the inner
diameter (b) of the outer flanged ring 6 are positioned within the flanges of the
outer ring. The inner flanged ring 8 is then inserted into the outer ring to form
a press-fit two-piece annular ring in which the guard disk pad(s) is (are) frictionally held within the press-fit ring or collar. Preferably, the inner diameter (b) of the outer flanged ring and the inner diameter (a) of the inner flanged ring are substantially the same.
Z Alternatively, the rigid annular outer ring can be incorporated into the guard disk holder or chromatographic column cap. The annular ring is a flange that is part of one or both sides of the disk holder or the column cap. In this case, the guard disk does not have an outer ring. A circle of the guard disk sheet material is placed into the holder or column cap. The flange in the holder column cap is annular so that, when the holder or column cap is tightened, the flange pinches or seals the outer annular portion of the guard disk. The center portion of the guard disk not pinched is in a chamber or depression in the holder or cap. Fluid flows through the center portion, allowing the guard disk to retain particulate or strongly adsorbed material, but fluid cannot flow around the disk or past the edges. The function of the guard disk is exactly the same as when the collar is part of the guard disk itself. However, in this case, the collar is part of the holder or column cap.
In a most preferred embodiment of the invention, a multivalent cation capture resin contained in a guard column, guard cartridge, or guard disk is placed upstream of the separation column. Most preferably, the guard column, cartridge, or disk containing the resin is placed upstream of the
sample injection valve. Although this is preferably a guard disk, a guard cartridge or column can be used as long as the dead volume of the cartridge or column is not excessive and an effective eluting solvent gradient can be produced.
Optimally, a guard disk, column, or cartridge can be placed before the injection valve and a second guard disk, column, or cartridge also placed between the sample injection valve and the separation column. In certain
cases, the second guard disk (or cartridge or column) can be avoided if the contaminants are sufficiently cleaned by a guard column placed upstream of the injection valve, or if the contaminants are avoided through the use of non- metal or titanium components throughout the HPLC system.
Placement of a chelating guard column and chelating guard disk in a liquid chromatography system for polynucleotide separation is illustrated in
FIG. 4. The eluting solvent reservoirs 12 contain eluting solvent inlet filters 14
which are connected to the solvent pump 16 by system tubing 18. The
solvent pump 16 is connected to a chelating column 20 by system tubing 18.
The chelating column 20 is connected to the sample injection valve 22 by
system tubing 18. The sample injection valve has means for injecting a
sample (not shown). The sample injection valve 22 is connected to a
chelating guard disk 24 by system tubing 18. The chelating guard disk 24 is
connected to the inlet (not shown) of the separation column 26 by system
tubing 18. Detector 28 is connected to the separation column 26. As discussed above, the system tubing, eluting solvent inlet filters, solvent pump, sample injection valve, and separation column are preferably made of titanium, coated stainless steel, or organic polymer. The material is preferably treated so that it does not release multivalent cations. The treatment can include treatment with nitric acid, phosphoric acid,
pyrophosphoric acid, or chelating agents. In cases, where components of the HPLC do not release metal ion contaminants and are suitable for
polynucleotide separations in general and MIPC in particular, then use of the chelating cation exchange guard column or guard disc is not necessary.
In operation, eluting solvent from the eluting solvent reservoirs 12 is
pumped through eluting solvent inlet filters 14 by solvent pump 16. By way of
^3 system tubing 18, the eluting solvent stream flows through chelating column
20, through sample injection valve 22, through chelating guard disk 24, then
into separation column 26. Detector 28 is located downstream from
separation column 26. FIG. 5 illustrates a specific embodiment of the invention in which a chelating guard disk is placed in direct contact with a titanium frit at the top
portion of a chromatographic separation column. Column top 30 has
conventional fittings for receiving eluting solvent and sample through inlet
tubing 32. The column top or cap 30 is fitted and sealably attached to column
body 34 containing chromatographic bed 36 using a conventional fitting 38 (e.g., threaded) or any equivalent fitting capable of tightly sealing the column
top to the column body. The column top 30 is adapted to receive the
chelating guard disk 40 in a sealing cavity 42. In this embodiment, the guard
disk 40 is in direct contact with a titanium column frit 44, which is located at
the upstream end of the column body 34 to prevent disturbance of the
chromatographic bed 36 when the column top 30 is removed to observe the
guard disk.
In operation, solvent pump 46 pumps elution solvent to sample
injection valve 48 into column top 30 through chelating guard disk 40 and
then through titanium frit 44 before entering chromatographic bed 36. Eluting
solvent pressure upstream from the guard disk is measured by pressure
transducer 50 which is electrically connected to a display device 52.
As discussed above, a chelating guard column, cartridge, or disk can be used in conjunction with a conventional, stainless steel liquid chromatography system, or with a system containing non-metal or titanium
2-H components in order to provide extra protection against ionic contaminants. For additional column protection, an eluting solvent containing OJ mM tetrasodium EDTA or other chelating solution can be used during the performance of polynucleotide separations. In another aspect of the invention the non-polar, wide pore separation
media have been washed to remove any traces of residual multivalent metal cations from the surface thereof. Preferred washing solvents comprise tetrahydrofuran, hydrochloric acid, and water. An example of a preferred washing procedure is described in Examplel . The methods of the invention comprise using the improved systems described above to separate mixtures of polynucleotide fragments, particularly double-stranded polynucleotide fragments. The methods of the present invention can be used to separate polynucleotide fragments having up to about 1500 base pairs using non-polar, wide pore separation media under the chromatography conditions described herein.
The most preferred method of the invention comprises contacting a
solution of a mixture of polynucleotide fragments containing a counterion agent with a multivalent metal cation capture resin, followed by application of said solution to a separation column containing non-polar, wide pore separation media wherein said particles have been washed to remove any traces of residual multivalent cation therefrom. Optimally, the process
solution contact surfaces of the system have been passivated, as described
hereinabove, to remove multivalent metal cations therefrom. In an optimum
configuration, a guard cartridge or guard column containing multivalent cation capture resin is placed at the front of the column or in line between the eluting
£5 solvent reservoir and the solvent pump(s) to protect said column and the separation media contained therein from any traces of residual multivalent metal cations in the eluting solvent. The polynucleotide fragments are separated by releasing said fragments from the separation media using an eluting solvent comprising an organic component, water, and a counterion agent. The separation of the polynucleotide components is based on the size or polarity of the fragments. By way of example only, the fragments are released from the separation media in order of size by increasing the concentration of organic component in the eluting solvent. The concentration of the organic component can be increased in stepwise fashion by means of a step gradient, or continuously, by means of a continuous gradient.
The methods used to capture multivalent cations and prevent their presence in the chromatography system, are essential in order to achieve high resolution separations of polynucleotides, especially double stranded DNA, and also to greatly extend the useful life of the separation media. Evidence demonstrating the detrimental effect of multivalent metal cation
contamination on the chromatographic separation of both single stranded polynucleotide fragments and double stranded polynucleotide fragments on
non-polar, wide pore silica and polymer separation media is presented in Examples 2 - 7 and FIGs. 6 - 15.
Example 2 describes a polynucleotide fragment separation on non- polar, wide pore organic polymer separation media using the optimized
method of the invention compared to a deliberate contamination of the system with multivalent metal cations. While a sharp peak is obtained using the optimized method of the invention, the peak is completely absent when the
Zζ chromatography system was deliberately contaminated with multivalent metal cations.
Example 3 is identical to Example 2, except that non-polar, wide pore silica separation media were used in the chromatography. In Example 4, a series of three separations of a 500 base pair DNA fragment was performed using non-polar, wide pore polymer separation media are described. In the first separation, the separation media was
washed to remove multivalent cations as described in Example 1 prior to sample injection, and a sharp peak was obtained as shown in FIG. 6. Deliberate contamination of this separation media with Cr (III) cations resulted in a complete loss of the sample peak as shown in FIG. 7. Treatment of the separation particles with EDTA solution to remove the Cr (III) and any other ions which may have been present, partially restored the sample peak as shown in FIG. 8.
Example 5 describes an sequence similar to Example 4, except that non-polar, wide pore silica separation media was used and washed with EDTA solution prior to sample injection. Once again, a sharp sample peak
was obtained, as shown in FIG. 9, when the sample was injected onto a column containing cleaned separation media. Deliberate contamination of the separation media with Cr(lll) resulted in complete loss of the sample peak, as shown in FIG. 10. Injection of EDTA solution to remove Cr(lll), or other multivalent cations, followed by injection of the 500 base pair DNA sample, partially restored the sample peak as shown in FIG. 11.
The deleterious effect of multivalent metal cations on the
chromatographic separation of a 20 mer single stranded DNA standard is described in Example 6 and shown by the complete loss of resolution as seen in FIG. 13 (after deliberate Cr (III) contamination) compared to FIG. 12 (column cleaned with EDTA).
The deleterious effect of even trace levels of multivalent cations on demanding chromatographic separation is described in Example 7 and shown
in FIGs. 14 and 15. A standard 4 component mixture of double stranded DNA consisting of two 209 base pair homoduplex fragments and two 209 base pair
heteroduplex fragments were chromatographed at 56 °C as described in
Example 6 on a freshly packed column DNASep column (Transgenomic, Inc., San Jose, CA). FIG. 14 shows only partial resolution of the 4 component mixture. However, when the column was treated with EDTA solution followed by re-injection and elution of the 4 component homoduplex/heteroduplex DNA mixture as described in Example 6, a clean separation of all 4 components was achieved, as seen in FIG. 15. This result clearly indicates that trace levels of multivalent cations were present in a freshly packed column, and that said cations interfered with the separation of double stranded DNA fragments.
The method of the invention can also be used to separate
polynucleotide mixtures in a batch process useful for production and isolation of pure polynucleotide fragments of a plurality of selected sizes, on a small or
large scale. The method of the invention comprises contacting a solution of a
mixture of polynucleotide fragments containing a counterion agent with a multivalent metal cation capture resin, followed by applying said solution to
non-polar, wide pore separation media. The separation media are held in a container. The container may be a column, a membrane, a container, or a
ZZ web. The polynucleotide mixture is held on the separation media since the concentration of the organic component of the solvent in which the mixture is dissolved is not sufficient to release the polynucleotide fragments therefrom. The separation media are then contacted with a first eluting solvent and a counterion agent, said first eluting solvent having a concentration of the organic component sufficient to remove all polynucleotide fragments from the separation media which are smaller than the selected size. The eluting solvent is then separated from the separation media. The separation media are rinsed with the first eluting solvent to remove any remaining released polynucleotides. The separation media are then contacted with a second eluting solvent and counterion agent, said second eluting solvent having a concentration of the organic component sufficient to release the polynucleotide fragment having the selected size from the separation media. The second eluting solvent is separated from the separation media and the particles are rinsed with the second eluting solvent. This process can be repeated to release polynucleotide of any selected size which are present in the mixture.
Specific eluting solvent compositions required to elute polynucleotide
fragments of any specific base pair length can be determined experimentally. For example, isolation of a 102 base pair fragment from the polynucleotide mixture may be desired, and said fragment may be eluted with 15.9%
acetonitrile-water-OJ M triethylammonium acetate. In this example, the separation media holding the polynucleotide mixture may be contacted with
14.6% acetonitrile-water-OJ M triethylammonium acetate to remove reaction mixture reagents and additives, as well as all fragments having less than 102 base pairs. Increasing the acetonitrile concentration to 15.9% followed by contact of this eluting solvent with the non-polar, wide pore separation media will release the desired 102 base pair fragment, leaving larger fragments still attached to the separation media. The desired polynucleotide fragment dissolved in the eluting solvent is isolated by separating the eluting solvent from the separation media by filtering, decanting, centrifuging, or any other
compatible liquid/solid separation technique. By using a step gradient of increasing acetonitrile concentration, larger particles may be removed in discreet base pair lengths from the separation media and isolated by repeating the procedure described hereinabove.
In a most preferred embodiment of the batch process of the invention, all the methods and procedures used to remove traces of multivalent cations from solvents and surfaces which contact process solution are identical to the methods and procedures described in separation method of the invention
described hereinabove. All of process solution contract surfaces are of materials which do not release multivalent cations. Said materials are identical to those described in the separation method of the invention hereinabove.
The methods used to capture multivalent cations and prevent their presence in the batch process described hereinabove, are essential in order
to achieve high resolution separations of polynucleotides, especially double stranded DNA, and also to greatly extend the useful life of the separation
media.
The concepts, materials, systems and methods related to
chromatographic separations on non-polar, wide pore separation media are well known and are described in detail in the following references: Chromatography Today, by Colin F. Poole and Salwa K. Pool, Elsevier (1991); Introduction to Modern Liquid Chromatography, L. R. Snyder and J. J. Kirland, J. Wiley and Sons, Inc. (1979). These references and references contained therein are incorporated in their entirety herein.
Non-polar, wide pore separation media and their use for the separation of polynucleotide mixtures are well known in the art and are commercially available, e.g., Hamilton HPLC Application Handbook, (1993), Hamilton Company, Inc., 4970 Energy Way, Reno, Nevada 89502. This, and references contained therein, are incorporated in their entirety herein. Another reference, which is incorporated in its entirety herein, describing polynucleotide separations on non-polar, wide pore reverse phase particles is Chromatography, 5th edition, Part B, edited by E. Heftmann, Elsevier (1992). Separation of tRNA and DNA fragment mixtures on non-polar, wide pore silica particles is described by R. Bischoff and L.W. McLaughlin, Analytical Biochemistry, 155, 526-533 (1985) and S. Eriksson, et. al., J. Chromatography, 359. 265-274 (1986). Regardless of the source or composition of the non-polar, wide pore separation media, precautions are taken to ensure that they are free of multivalent cation contaminants. For example, the separation media are washed with acid followed by methanol to ensure removal of residual multivalent cation contaminants.
Procedures described in the past tense in the examples below have been carried out in the laboratory. Procedures described in the present tense have not been carried out in the laboratory, and are constructively reduced to practice with the filing of this application. Example 1
Acid Wash Treatment To Remove Multivalent Metal Cation Contaminants The non-polar, wide pore reverse phase separation media were washed three times with tetrahydrofuran, then two times with methanol. The non-polar, wide pore separation media were then stirred for 12 hours with a mixture containing 100 mL of tetrahydrofuran and 100 mL of concentrated hydrochloric acid. Following this acid treatment, the non-polar, wide pore separation media were washed with tetrahydrofuran/water (1 :1) until neutral
(pH 7). The non-polar, wide pore separation media were then dried at 40°C
for 12 hours.
Example 2 Standard Procedure for Demonstrating the Effects of Colloidal Iron on
Non-polar, Wide pore Polymer Separation Media Non-polar, wide pore PRX-1 separation media (Sarasep, Inc. San Jose, CA.) of polystyrene/divinylbenzene polymer having a pore size of 50 - 200 Angstroms (average pore size is 80 Angstroms) and a bead diameter of 5 microns are washed as described in Example 1 and packed in a 4.6 x 50 mm
HPLC column. A sample (5 μL, 20 ng) of 80 base pair DNA standard solution
from purified pUC18 DNA Hae III restriction enzyme digest (Sigma-Aldrich, D6293) is injected onto the column. The chromatography is conducted under
the following conditions: Eluting solvent A: 0.1 M Triethylammonium acetate (TEAA), pH 7.2; Eluting solvent B: 0.1 M TEAA, 25% acetonitrile; Gradient: Time (min) %A %B
0.0 65 35 3.0 45 55 10.0 35 65
14.0 0 100
16.0 65 35
The flow rate is 0.75 mL/min, UV detection at 260 nm, column temp.
51 °C. A peak for the 80 base pair DNA fragment is obtained. Some
columns, depending on the packing volume and packing polarity, may require longer time for elution of some changes in the driving solvent concentration. A 0.05M aqueous solution of Fe(CI)3 is prepared and allowed to stand
at ambient temperature for four hours. A 100 μL sample of the resulting
colloidal iron suspension is injected onto the column and allowed to stand for
five minutes. Subsequent injection of 5 μL of the above described 80 base
pair DNA standard solution followed by the identical gradient elution conditions described above, shows a complete absence of any peak.
Example 3 Standard Procedure for Demonstrating the Effects of Colloidal Iron on
Non-polar, Wide pore Silica Separation Media
INERTSIL (MetaChem, Torrance, CA), a 5μm C-18 non-polar, wide
pore separation medium having 200 Angstrom pores was packed in a 4.6 x 50 mm HPLC column and cleaned with 5 injections of 0J M Na4EDTA. A 80
base pair DNA standard (5 μL) is injected and eluted as described in Example
2. A peak for the 80 base pair DNA standard is obtained.
An injection of the colloidal iron suspension is made as described in Example 3. Subsequent injection of the 80 base pair DNA standard and elution as described in Example 3 shows a complete absence of any peak. Example 4 Standard Procedure for Demonstrating the Effects of Chromium(lll) On The Separation of Double Stranded DNA Using Non-polar, Wide Pore
Polymer Separation Media Non-polar, wide pore PRX-1 separation media (Sarasep, Inc., San
Jose, CA) of polystyrene/divinylbenzene polymer having a 5 micron diameter
and a pore size of 50 - 200Angstroms (80 Angstrom average pore size) was washed as described in Example 1 and packed in 4.6 x 50 mm HPLC column.
A sample (5μL, 20 ng) of 500 base pair DNA standard solution from
GeneAmpR Lambda Control Reagent, N808-0008, (Perkin Elmer, Foster City, CA) was injected onto the column. The chromatography was conducted under the following conditions: eluting solvent A; 0.1 M triethylammonium acetate (TEAA), pH 7.2; eluting solvent B; 0.1 M TEAA, 25% acetonitrile gradient:
Time (min) %A %B 0.0 60 40
14 0 100
17 60 40
The flow rate was 0.60 mL/min, UV detection at 260 nm, column
temperature 50 °C. A peak for the 500 base pair DNA fragmetn was
obtained , as shown in Fig. 6.
A 520 ppm aqueous solution of Cr(lll) was prepared from Cr3(S04)2.
12H20 and injected onto the column. The 17 min. solvent gradient was
flowed through the column. Injection of 5 μL of the 500 base pair DNA
standard onto the column and elution as described above, showed a complete absence of any peak (FIG. 7).
3t» A subsequent column cleanup with 3 injections, 10 μL
each, of OJ M Na4EDTA was followed by equilibration to a constant baseline.
A re-injection of 5 μL of the 500 base pair DNA standard showed a
reappearance of the a peak (FIG.8) having an area of about 50% of the original injection (FIG. 6).
Example 5 Standard Procedure for Demonstrating the Effects of Chromium(lll) ) On The Separation of Double Stranded DNA Using Non-polar, Wide Pore
Silica Separation Media INERTSIL (MetaChem, Torrance, CA) 5 micron C-18 non-polar, wide pore (150 Angstrom pores) separation media was packed into a 4.6 x 50 mm HPLC column and cleaned with 5 injections of 0J M Na4EDTA. A 500 base pair DNA standard was injected onto the column and eluted as described in Example. 4. A peak fo rthe 500 bas pair standard is shown in FIG. 9. Injection of the Cr(lll) solution as described in Example 4 followed by elution as described in Example 4, showed a complete absence of a peak as shown in FIG. 10.
Three 10 mL injections of Na4EDTA as described in Example 4 follwed by reinjection of the 500 base pair DNA standard and elution as described in
Example 4, showed a peak (FIG. 11)corresponding to the 500 base pair DNA standard
Example 6
The Effect of Chromium(lll) on The Separation of Single Stranded DNA
Using Non-polar, Wide Pore Silica Separation Media The column described in Example 5 was cleaned with Na4EDTA as decribed in Example 5 and equilibrated with 60%A eluting solvent to a constant bse line. A 20 mer, single stranded DNA standard (Seq2A purchased from CTGen, Milpitas, CA) was injected onto the column and eluted with the gradient protocol of Example 4. FIG 12 shows a major peak corresponding to the 20 mer standard and some well resolved impurity peaks.
A single 5 mL injection of the Cr(lll) solution described in Example 4 was followed by re-injection of the 20 mer standard and elution using the gradient protocol of Example 4. The results seen in FIG. 13 show a greatly diminished peak corresponding to the 20 mer, and essentially no resolution of the impurities.
This example clearly show that metal contamination has a negative effect on the chromatography of single stranded DNA but not to the same extent as it has on double stranded DNA.
An additional injection of 5 μL onto the column followed by another
injection of the 20 mer standard as described above, did result in complete elimination of the 20 mer peak. However, after 10 injections of 0J M
Na4EDTA to remove metal contamination, as described above, followed by another injection of the 20 mer standard, did restore the peak corresponding to the 20 mer standard. However, the peak shape was distorted and broad.
Example 7
The Effect Of Metal Contamination On The Separation Of
Heteroduplexes And Homoduplexes
A freshly packed DNASep column (Transgenomic, Inc., San Jose, CA) was equilibrated with eluting solvent 50%A. A mixture of DNA 209 base pair standard fragments (Transgenomic, Inc., San Jose, CA, Cat. No. 560012) consisting of 2 heteroduplex DNA fragmetns and 2 homoduplex DNA fragments was injected (5 μL) onto the column. The mixture was eluted at a
flow rate of 0.9 mL/min using the following gradient program: Time (min) %A %B
0.0 50 5
05 47 53
4.0 40 60
5.5 0 100 6.5 50 50
8.5 50 50
When the chromatography was run at 50 °C a normal size based
separation was observed, i.e., a single peak of unresolved hetroduplex and homoduplex 209 base pair fragments was observed.
FIG. 14 shows the results of a chromatography run at 56 °C, on a
newly packed column. Three peaks are seen. The low retention time pair corresponds to the two heteroduplexes. The large higher retention time peak corresponds to the unresolved homoduplex peaks. The lack of complete separation of all four fragments indicated that the column, though freshly packed, contained multivalent metal cation contaminants.
Column cleanup with 5, 10 μL injections of 0.1 M Na4EDTA was
followed by washing with 25% actonitrile, 5% acetic acid, and equilibration to constant base line with eluting solvent 50%A. Injection of the 209 fragment
standard homoduplex/heteroduplex mixture and elution with the gradient protocol described above, gave complete separation of the mixture into four
3?- peaks, i.e., two homoduplex and 2 heteroduplex peaks as depicted in FIG. 15.
The results described in this example indicate that multivalent metal
cation contamination is more critical at higher column temperatures, especially as related to the difficult separation of homoduplex and heteroduplex fragments of identical base pair length.
33

Claims

What is claimed is:
1. A method for separating a mixture of polynucleotide fragments comprising a) applying a solution of said fragments and counterion reagent to a column containing, separation media having a non-polar surface, wherein said separation media have a pore size greater than 30 Angstroms and an average diameter of 1-100 microns;
b) eluting said fragments with a gradient eluting solvent of increasing organic component concentration containing a counterion agent; wherein surfaces which are contacted by the solution of the fragments and the eluting solvent are materials which do not trap or release multivalent metal cations therefrom.
2. A method of Claim 1 wherein the solution of said fragments and the eluting solvent are contacted with a multivalent cation capture resin to remove any multivalent cations therein before entering the column.
3. A method of Claim 2 wherein said separation media have been treated
to remove residual traces of multivalent cations from the surfaces thereof.
4. A method of Claim 3 wherein the solution of said fragments and eluting solvent have been contacted with a multivalent cation capture resin before entering the column.
5. A method of Claim 4 wherein the polynucleotide fragments are double stranded or single stranded.
33
6. A method of Claim 5 wherein the fragments having more than 5 base pairs are separated on the basis of size or polarity.
7. A method of Claim 4 wherein said separation media are organic polymer.
8. A method of Claim 4 wherein said separation media have inorganic substrates selected from the group consisting of inorganic substrates, silica, zirconia, and alumina.
9. A method of Claim 8 wherein the non-polar surface is an organic polymer supported on the inorganic substrate.
10. A method of Claim 8 wherein the non-polar surface includes long chain hydrocarbon groups having from 8 to 24 carbons bound to the inorganic substrate.
11. A method of Claim 10 wherein residual polar groups of the inorganic substrate have been end capped with trimethylsilyl chloride or
hexamethyldisilazane.
12. A method of Claim 4, wherein the surfaces contacted by the solution of polynucleotide fragments and eluting solvent are titanium, coated stainless steel, organic polymer or combinations thereof.
13. A method of Claim 12 wherein traces of residual multivalent metal cations have been removed from said surfaces by treating said
surfaces with a solution comprising aqueous acid and chelating agent.
14. A method of Claim 12 wherein organic contaminants have been removed from said surfaces.
l 0
5. A method of Claim 1 wherein said solution of polynucleotide mixture and eluting solvent contain a chelating agent, whereby any trace of multivalent metal cations in the solutions are captured.
16. A method of Claim 4 wherein said solution of polynucleotide mixture and eluting solvent contain a chelating agent, whereby any trace of multivalent metal cations in the solutions are captured.
17. A method of Claim 4 wherein the eluting solvent has been treated to remove oxygen therefrom.
18. A method of Claim 4 wherein said method for separating said mixture of polynucleotides comprises Matched Ion Polynucleotide Chromatography.
19. A batch process for separating polynucleotide fragments having a selected size from a mixture of polynucleotide fragments including fragments of said selected size comprising a) applying a solution of said polynucleotide fragments and a counterion agent to non-polar separation media having a non- polar surface, wherein said separation media have a pore size greater than 30 Angstroms and an average diameter of 1 -100 microns;
b) contacting the separation media with a first eluting solvent and counterion agent, the first eluting solvent having a concentration
of organic component sufficient to release from the separation media all polynucleotide fragments having a size smaller than the selected size and removing the first eluting solvent from the separation media; and c) contacting the separation media with a second eluting solvent having a concentration of organic component sufficient to release from the separation media the polynucleotide fragments having the selected size and removing the second eluting solvent from the separation media; wherein surfaces which are contacted by the solution of polynucleotide fragments and the eluting solvent are material which does not trap or release multivalent metal cations therefrom.
20. A batch process of Claim 19 wherein the separation media are rinsed with fresh first eluting solvent following step b) to remove residual released polynucleotide fragments therefrom.
21. A batch process of Claim 19 wherein the separation media are rinsed with fresh second eluting solvent following step c) to remove residual
released polynucleotide fragments of selected size therefrom.
22. A batch process of Claim 19 wherein the solution of polynucleotide mixture and eluting solvent have been contacted with a multivalent cation capture resin before contacting the separation media.
23. A batch process of Claim 19 wherein the polynucleotide mixture is double stranded or single stranded.
24. A batch process of Claim 22 wherein said separation media have been
treated to remove residual traces of multivalent cations therefrom.
kz
25. A batch process of Claim 24 wherein the solution of polynucleotide mixture and eluting solvent have been contacted with a multivalent cation capture resin before contacting the separation media.
26. A batch process of Claim 25 wherein the separation media are contained in a column, a web, a membrane, or container.
27. A batch process of Claim 26 wherein said separation media are organic polymer or inorganic substrates selected from the group consisting of inorganic substrates, silica, zirconium, and alumina.
28. A batch process of Claim 27 wherein the non-polar surface is an organic polymer supported onlhe inorganic substrate.
29. A batch process of Claim 27 wherein the non-polar surface includes long chain hydrocarbons having from 8-24 carbons bonded the inorganic substrate.
30. A batch process of Claim 29 wherein any residual polar groups of the inorganic substrate have been end capped with trimethylsilyl chloride or hexamethyldisilazane.
31. A batch process of Claim 26, wherein the surfaces contacted by the solution of polynucleotide fragments and eluting solvent are comprised of material selected from the group consisting of titanium, coated
stainless steel, and organic polymer, or combinations thereof.
32. A batch process of Claim 31 wherein traces of residual multivalent
metal cations have been removed from said surfaces by treating said surfaces with a solution comprising aqueous acid and chelating agent.
33. A batch process of Claim 31 wherein organic contaminants have been removed from said surfaces.
f\b
34. A batch process of Claim 25 wherein said solution of polynucleotide mixture and eluting solvent contain a chelating agent whereby any trace of multivalent metal cations in the solution are captured.
35. A batch process of Claim 19 wherein the eluting solvent has been treated to remove oxygen therefrom.
fi
EP98923524A 1997-06-10 1998-05-19 Improved process for performing polynucleotide separations Withdrawn EP1025113A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4912397P 1997-06-10 1997-06-10
US49123P 1997-06-10
US6383597P 1997-10-30 1997-10-30
US63835P 1997-10-30
PCT/US1998/010228 WO1998056798A1 (en) 1997-06-10 1998-05-19 Improved process for performing polynucleotide separations

Publications (2)

Publication Number Publication Date
EP1025113A1 true EP1025113A1 (en) 2000-08-09
EP1025113A4 EP1025113A4 (en) 2002-01-09

Family

ID=26726874

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98923524A Withdrawn EP1025113A4 (en) 1997-06-10 1998-05-19 Improved process for performing polynucleotide separations

Country Status (5)

Country Link
EP (1) EP1025113A4 (en)
JP (1) JP2001524133A (en)
AU (1) AU743789B2 (en)
CA (1) CA2288813A1 (en)
WO (1) WO1998056798A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576133B2 (en) 1996-11-13 2003-06-10 Transgenomic, Inc Method and system for RNA analysis by matched ion polynucleotide chromatography
US6475388B1 (en) 1996-11-13 2002-11-05 Transgenomic, Inc. Method and system for RNA analysis by matched ion polynucleotide chromatography
US7138518B1 (en) 1996-11-13 2006-11-21 Transgenomic, Inc. Liquid chromatographic separation of polynucleotides
US6258264B1 (en) 1998-04-10 2001-07-10 Transgenomic, Inc. Non-polar media for polynucleotide separations
WO2001066216A1 (en) * 2000-03-09 2001-09-13 Transgenomic, Inc. Method and system for rna analysis by matched ion polynucleotide chromatography
WO2001081566A2 (en) * 2000-04-21 2001-11-01 Transgenomic, Inc. Apparatus and method for separating and purifying polynucleotides
US6521411B2 (en) * 2000-09-28 2003-02-18 Transgenomic, Inc. Method and system for the preparation of cDNA
WO2002040130A1 (en) * 2000-11-16 2002-05-23 Transgenomic, Inc. Liquid chromatographic separation of polynucleotides
US20020086291A1 (en) * 2000-11-29 2002-07-04 Hornby David P. Methods and reagents for analysis of rna structure and function
WO2003031580A2 (en) 2001-10-05 2003-04-17 Transgenomic, Inc. Methods and compositions for mutation analysis by liquid chromatography
WO2004047981A1 (en) * 2002-11-25 2004-06-10 Varian, Inc. Irregularly-shaped macroporous copolymer particles and methods of using same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338448A (en) * 1992-10-16 1994-08-16 Sarasep, Inc. Method of preventing contamination of a chromatography column
US5482628A (en) * 1994-04-15 1996-01-09 Upchurch Scientific, Inc. Column for liquid chromatography

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT398973B (en) * 1992-11-18 1995-02-27 Bonn Guenther Dr METHOD FOR SEPARATING NUCLEIC ACIDS

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338448A (en) * 1992-10-16 1994-08-16 Sarasep, Inc. Method of preventing contamination of a chromatography column
US5482628A (en) * 1994-04-15 1996-01-09 Upchurch Scientific, Inc. Column for liquid chromatography

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9856798A1 *

Also Published As

Publication number Publication date
CA2288813A1 (en) 1998-12-17
WO1998056798A1 (en) 1998-12-17
JP2001524133A (en) 2001-11-27
AU743789B2 (en) 2002-02-07
EP1025113A4 (en) 2002-01-09
AU7579698A (en) 1998-12-30

Similar Documents

Publication Publication Date Title
US6156206A (en) Process for performing polynucleotide separations
US6251272B1 (en) System and column for performing polynucleotide separations using liquid chromatography
US5772889A (en) System and method for performing nucleic acid separations using liquid chromatography
US6030527A (en) Apparatus for performing polynucleotide separations using liquid chromatography
EP1023306B1 (en) System and method for performing polynucleotide separations using liquid chromatography
US6017457A (en) Method for performing polynucleotide separations using liquid chromatography
US6066258A (en) Polynucleotide separations on polymeric separation media
US6174441B1 (en) Method for performing polynucleotide separations using liquid chromatography
AU743789B2 (en) Improved process for performing polynucleotide separations
US6475388B1 (en) Method and system for RNA analysis by matched ion polynucleotide chromatography
Hawk et al. Chromatography of biological materials on polyethylene glycol treated controlled-pore glass
US6521411B2 (en) Method and system for the preparation of cDNA
US6471866B1 (en) Process for performing polynucleotide separations
US6579459B2 (en) System and method for performing polynucleotide separations using liquid chromatography
US5986085A (en) Matched ion polynucleotide chromatography (MIPC) process for separation of polynucleotide fragments
US6576133B2 (en) Method and system for RNA analysis by matched ion polynucleotide chromatography
US6177559B1 (en) Process for separation of polynucleotide fragments
AU777251B2 (en) Polynucleotide separations on polymeric separation media
CA2375746A1 (en) Improved column for dna separation by matched ion polynucleotide chromatography
US6482317B2 (en) Polynucleotide separations on polymeric separation media
US20010051715A1 (en) Chromatographic method for RNA stabilization
WO2001066216A1 (en) Method and system for rna analysis by matched ion polynucleotide chromatography
Wulfson et al. HPLC of nucleotides. II. General methods and their development for analysis and preparative separation. An approach to selectivity control
JPS63281051A (en) Treatment of sample
JP2006340649A (en) Method for refining nucleic acid

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991231

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20011127

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07H 1/00 A, 7B 01D 15/08 B

17Q First examination report despatched

Effective date: 20020115

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20031202